ETHICS BLOG: How to listen to (the right) patient voices?

Ulrik Kihlbom, co-lead for the work to assess methodologies, writes about some of the challenges to finding the patients voice.

(Image removed) Ulrik Kihlbom, public co-lead for methodology (Link removed)

Ulrik Kihlbom is public co-lead for PREFER's work on methodology. He has a background in philosophy and when he is not involved in PREFER, he works as a Senior Lecturer in medical ethics at Uppsala University.

Read his thoughts on some of the more philosophical questions this project raises on the Ethics Blog.

CONTACT US

X: @IMI_PREFER

LinkedIn

YouTube

  •  
  • Disclaimer: This website and its contents reflects the PREFER project's view and not the view of IMI, the European Union or EFPIA.
  •  

PREFER

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).